NCT03370029

Brief Summary

Primary ciliary dyskinesia is an autosomal recessive disorder characterized by abnormal ciliary movement and disrupted mucociliary clearance. In uncleaned airways, microorganisms and respiratory irritants cause inflammation and infection. Permanent rhinitis and chronic sputum cough are typical features in primary ciliary dyskinesia patients. Primary ciliary dyskinesia is a disease that threatens lung function from pre-school age. One of the main causes of respiratory muscle weakness in chronic lung diseases diseases is worsening of lung function. Such a weakness causes alveolar hypoventilation, microatelectasis, reduction of the cough strength .The cough strength is important for airway cleaning. Exercise capacity is affected in chronic lung diseases. Assessment of exercise capacity in chronic lung diseases is prognostically important. Reduced exercise capacity and pulmonary function in PCD cause decrease in physical activity level. PCD patients have low quality of life and early recognition has been found to affect the quality of life positively. Children with chronic illness have higher level of depression than healthy children. In literature, no study investigated respiratory muscle strength, exercise capacity and physical activity PCD patients. Therefore, the investigators aimed to compare aforementioned outcomes in PCD patients and healthy controls.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2016

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

November 10, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 12, 2017

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 25, 2018

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2018

Completed
Last Updated

February 15, 2019

Status Verified

February 1, 2019

Enrollment Period

1.4 years

First QC Date

November 10, 2017

Last Update Submit

February 13, 2019

Conditions

Keywords

Exercise capacityRespiratory muscle strengthPhysical inactivityQuality of life

Outcome Measures

Primary Outcomes (4)

  • Respiratory muscle strength

    Evaluated using mouth pressure device

    first day

  • Functional exercise capacity

    Evaluated using 6-minute walking test

    first day

  • Anaerobic exercise capacity

    Evaluated using 3-minute step test

    first day

  • Physical activity

    Evaluated using a metabolic holter

    first day

Secondary Outcomes (8)

  • Pulmonary functions

    first day

  • Muscle strength

    second day

  • Cough strength

    second day

  • Respiratory muscle endurance

    second day]

  • Activity dyspnea

    first day

  • +3 more secondary outcomes

Study Arms (2)

Primary ciliary dyskinesia patients

Primary ciliary dyskinesia patients will be included in study. Inclusion and exclusion criteria were considered.

Healthy individuals

Those without diagnosed chronic disease will be included in study. Inclusion and exclusion criteria were considered.

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Out- patients and healthy volunteers

You may qualify if:

  • Diagnosed primary ciliary dyskinesia patients,
  • years of age,
  • under standard medications,
  • stable patients without exacerbation or infection

You may not qualify if:

  • having cognitive disorder,
  • orthopedic or neurological disease with a potential to affect functional capacity,
  • acute infections or pneumonia,
  • problems which may prevent evaluating such as visual problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gazi University Faculty of Health Sciences Department of Physical Therapy and Rehabilitation

Yenimahalle, Turkey (Türkiye)

Location

Related Publications (2)

  • Firat M, Bosnak-Guclu M, Sismanlar-Eyuboglu T, Aslan AT. Aerobic exercise capacity, cough strength, posture, and depression in primary ciliary dyskinesia. Pediatr Pulmonol. 2023 Jan;58(1):73-80. doi: 10.1002/ppul.26158. Epub 2022 Sep 28.

  • Firat M, Bosnak-Guclu M, Sismanlar-Eyuboglu T, Tana-Aslan A. Respiratory muscle strength, exercise capacity and physical activity in patients with primary ciliary dyskinesia: A cross-sectional study. Respir Med. 2022 Jan;191:106719. doi: 10.1016/j.rmed.2021.106719. Epub 2021 Dec 17.

Related Links

MeSH Terms

Conditions

Ciliary Motility DisordersSedentary Behavior

Condition Hierarchy (Ancestors)

Respiratory Tract DiseasesOtorhinolaryngologic DiseasesCiliopathiesAbnormalities, MultipleCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGenetic Diseases, InbornBehavior

Study Officials

  • Merve Fırat, Pt

    Research assistant

    STUDY CHAIR
  • Meral Boşnak Güçlü, Pt,Phd

    Associate professor

    STUDY DIRECTOR
  • Tuğba Şişmanlar Eyüboğlu, MD

    Medical doctor

    PRINCIPAL INVESTIGATOR
  • Ayşe Tana Aslan, MD,Phd

    Professor

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

November 10, 2017

First Posted

December 12, 2017

Study Start

October 1, 2016

Primary Completion

February 25, 2018

Study Completion

June 30, 2018

Last Updated

February 15, 2019

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will not share

There is not a plan to make individual participant data but when the statistical analyses of all data are made, all results will be shared.

Locations